A perfectly matched layer formulation for modeling transient wave propagation in an unbounded fluid-solid medium.

J Acoust Soc Am

Institute of Biomaterials and Biomedical Engineering, University of Toronto, 164 College Street, Toronto M5S 3G9, Canada.

Published: April 2016

Wave propagation in an infinite medium can be numerically simulated by surrounding a finite region by a perfectly matched layer (PML). When the medium is heterogeneous consisting of both solids and liquids, careful consideration is needed in specifying the properties of the PML especially because parts of it lie at the solid-fluid interface. While such a situation could arise in many important fields including marine seismology, where water is in contact with earth, and in biomedical ultrasound, where soft tissue is in contact with bone, no PML formulation exists to appropriately model such coupled problems. Here, a second-order time-domain PML formulation for fluid-solid heterogeneous media in two dimensions that satisfies the interface coupling boundary condition throughout the computational domain is presented. Numerical results are given to establish the applicability and accuracy of such a PML formulation in discrete settings without causing stability issues, spurious reflections, or any other problems. In particular, the effectiveness of the PML in absorbing all kinds of bulk waves, as well as surface and evanescent waves, is studied.

Download full-text PDF

Source
http://dx.doi.org/10.1121/1.4944793DOI Listing

Publication Analysis

Top Keywords

pml formulation
12
perfectly matched
8
matched layer
8
wave propagation
8
pml
6
formulation
4
layer formulation
4
formulation modeling
4
modeling transient
4
transient wave
4

Similar Publications

Micro-nano-plastic (MNP) particles (p) in the environment can enter the human body and pose a potential threat to human health. However, it is unknown whether these substances are present in polypropylene (PP) plastic-bottled injections, which are used as high-frequency intravenous infusions to treat diseases. Therefore, the objective of this study was to identify and quantify insoluble MNP particles in 16 batches of injectable formulations within the validity period.

View Article and Find Full Text PDF

Chemotherapy-free approaches to newly-diagnosed acute promyelocytic leukaemia: is oral-arsenic trioxide/all-trans retinoic acid/ascorbic acid the answer?

Expert Rev Hematol

October 2024

Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

Introduction: Acute promyelocytic leukemia (APL) is a distinct form of acute myeloid leukemia characterized by the presence of t(15;17)(q24;21) and the gene fusion. Frontline use of intravenous arsenic trioxide (i.v.

View Article and Find Full Text PDF

Lung cancer is the leading cause of global cancer death and prevention strategies are key to reducing mortality. Medical prevention may have a larger impact than treatment on mortality by targeting high-risk populations and reducing their lung cancer risk. Premalignant lesions (PMLs) that can be intercepted by prevention agents are difficult to study in humans but easily accessible in murine preclinical carcinogenesis studies.

View Article and Find Full Text PDF

Seasonal influenza vaccines must be updated annually and suboptimally protect against strains mismatched to the selected vaccine strains. We previously developed a subunit vaccine antigen consisting of a stabilized trimeric influenza A group 1 hemagglutinin (H1) stem protein that elicits broadly neutralizing antibodies. Here, we further optimized the stability and manufacturability of the H1 stem antigen (H1 stem v2, also known as INFLUENZA G1 mHA) and characterized its formulation and potency with different adjuvants in vitro and in animal models.

View Article and Find Full Text PDF

Effective antiviral treatments for coronavirus disease 2019 (COVID-19) are needed to reduce the morbidity and mortality associated with severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection, particularly in patients with risk factors for severe disease. Molnupiravir (MK-4482, EIDD-2801) is an orally administered, ribonucleoside prodrug of β-D-N4-hydroxycytidine (NHC) with submicromolar potency against SARS-CoV-2. A population pharmacokinetic (PopPK) analysis for molnupiravir exposure was conducted using 4202 NHC plasma concentrations collected in 1207 individuals from a phase I trial in healthy participants, a phase IIa trial in non-hospitalized participants with COVID-19, a phase II trial in hospitalized participants with COVID-19, and a phase II/III trial in non-hospitalized participants with COVID-19.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!